Related Experiment Videos
[Ethical problems in genetics and reproduction medicine]
1Klinischen Abteilung für Endokrinologie und Sterilitätsbehandlung, Universitätsklinik für Frauenheilkunde, Wien. christian_gruber@chello.at
Wiener Medizinische Wochenschrift (1946)
|August 10, 2002
Summary
Advances in molecular biology, genetics, and reproductive medicine offer new therapies but raise ethical questions. Open discussions, differentiating "to be alive" from "to have a life," are crucial for beneficial progress.
Area of Science:
- Molecular Biology
- Genetics
- Reproductive Medicine
Context:
- Emerging knowledge in molecular biology, genetics, and reproductive medicine is poised to transform healthcare.
- New therapeutic avenues present complex ethical dilemmas, including preimplantation diagnostics, embryonic stem cell research, and gene therapy.
Purpose:
- To address the ethical considerations arising from advancements in molecular biology, genetics, and reproductive medicine.
- To foster informed discussions by distinguishing between scientific progress and potential risks, and between individual morality and general ethics.
Summary:
- Scientific progress in life sciences is advancing rapidly, necessitating a re-evaluation of ethical frameworks.
- Key ethical challenges include preimplantation diagnostics, embryonic stem cell research, and gene therapy, requiring careful consideration.
- Distinguishing between 'to be alive' and 'to have a life' is proposed for a future definition of 'life'.
Impact:
- Encourages a balanced perspective on scientific innovation, acknowledging both potential benefits and inherent dangers.
- Advocates for flexibility and open dialogue to navigate the ethical landscape of future medical developments.
- Highlights the importance of differentiating personal moral claims from universal ethical principles in ongoing debates.